{"id":"https://openalex.org/W2042899751","doi":"https://doi.org/10.1177/095632029901000303","title":"Role of Lentiviral Lytic Polypeptide I (LLP-I) in the Selective Cytotoxicity of \u03b3-Glutamylcysteine Ethyl Ester against Human Immunodeficiency Virus Type 1-Producing Cells","display_name":"Role of Lentiviral Lytic Polypeptide I (LLP-I) in the Selective Cytotoxicity of \u03b3-Glutamylcysteine Ethyl Ester against Human Immunodeficiency Virus Type 1-Producing Cells","alternate_titles":[],"publication_year":1999,"publication_date":"1999-06-01","ids":{"openalex":"https://openalex.org/W2042899751","doi":"https://doi.org/10.1177/095632029901000303","mag":"2042899751","pmid":"https://pubmed.ncbi.nlm.nih.gov/10431611"},"language":"en","primary_location":{"id":"doi:10.1177/095632029901000303","doi":"https://doi.org/10.1177/095632029901000303","is_oa":false,"landing_page_url":"https://doi.org/10.1177/095632029901000303","pdf_url":null,"source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2042899751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Satoshi Kubota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satoshi Kubota","raw_affiliation_strings":["The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323555","display_name":"Hui Zhang","orcid":"https://orcid.org/0000-0003-3620-610X","observed_orcids":["https://orcid.org/0000-0003-3620-610X"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hui Zhang","raw_affiliation_strings":["The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","#N# 1 The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"#N# 1 The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074082033","display_name":"Shigehisa Kitahara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90469020","display_name":"Teijin (Japan)","ror":"https://ror.org/038kxkq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I90469020"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shigehisa Kitahara","raw_affiliation_strings":["Teijin Institute for Bio-Medical Research, Hino, Japan","#N# 2 Teijin Institute for Bio-Medical Research, Hino, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teijin Institute for Bio-Medical Research, Hino, Japan","institution_ids":["https://openalex.org/I90469020"]},{"raw_affiliation_string":"#N# 2 Teijin Institute for Bio-Medical Research, Hino, Japan","institution_ids":["https://openalex.org/I90469020"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108589893","display_name":"Roger J. Pomerantz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger J Pomerantz","raw_affiliation_strings":["The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","#N# 1 The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"#N# 1 The Dorrance H Hamilton Laboratories, Center for Human Virology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA","institution_ids":["https://openalex.org/I149251103"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"3","first_page":"121","last_page":"126"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.8564000129699707,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.041099999099969864,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.017500000074505806,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9390000104904175},{"id":"https://openalex.org/keywords/gp41","display_name":"gp41","score":0.8140000104904175},{"id":"https://openalex.org/keywords/envelope-glycoprotein","display_name":"envelope glycoprotein","score":0.8140000104904175},{"id":"https://openalex.org/keywords/selective-cytotoxicity","display_name":"selective cytotoxicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.7889999747276306},{"id":"https://openalex.org/keywords/melittin","display_name":"melittin","score":0.9240000247955322},{"id":"https://openalex.org/keywords/hiv-infected-t-cells","display_name":"HIV-infected T cells","score":0.6340000033378601},{"id":"https://openalex.org/keywords/cell-death-mechanisms","display_name":"cell death mechanisms","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.8855606317520142},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7497103214263916},{"id":"https://openalex.org/C182615771","wikidata":"https://www.wikidata.org/wiki/Q1369386","display_name":"Lytic cycle","level":3,"score":0.6773998141288757},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5518423914909363},{"id":"https://openalex.org/C2778001312","wikidata":"https://www.wikidata.org/wiki/Q424512","display_name":"Melittin","level":3,"score":0.49301430583000183},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.48539671301841736},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4789853096008301},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.46619051694869995},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.4353906214237213},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3762526512145996},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3386033773422241},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2911912798881531},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27593326568603516},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22341614961624146},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.19011229276657104},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004151","descriptor_name":"Dipeptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008555","descriptor_name":"Melitten","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008555","descriptor_name":"Melitten","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015700","descriptor_name":"HIV Envelope Protein gp41","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/095632029901000303","doi":"https://doi.org/10.1177/095632029901000303","is_oa":false,"landing_page_url":"https://doi.org/10.1177/095632029901000303","pdf_url":null,"source":{"id":"https://openalex.org/S201936961","display_name":"Antiviral chemistry & chemotherapy","issn_l":"0956-3202","issn":["0956-3202","2040-2066"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Chemistry and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:10431611","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10431611","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral chemistry & chemotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1510416349","https://openalex.org/W1712483123","https://openalex.org/W1969899610","https://openalex.org/W2004405778","https://openalex.org/W2010479937","https://openalex.org/W2011630381","https://openalex.org/W2021366999","https://openalex.org/W2028384041","https://openalex.org/W2028399135","https://openalex.org/W2074681297","https://openalex.org/W2075971959","https://openalex.org/W2077684471","https://openalex.org/W2077847842","https://openalex.org/W2085951021","https://openalex.org/W2093517549","https://openalex.org/W2104135646","https://openalex.org/W2133759756","https://openalex.org/W2169962760","https://openalex.org/W2401546186"],"related_works":["https://openalex.org/W2408856569","https://openalex.org/W2169962760","https://openalex.org/W2052683909","https://openalex.org/W2114816852","https://openalex.org/W2076364351","https://openalex.org/W1969880686","https://openalex.org/W1997937309","https://openalex.org/W2102731379","https://openalex.org/W2138370250"],"abstract_inverted_index":{"Selective":[0],"cytotoxic":[1,59,99],"effects":[2,27,80],"of":[3,25,36,43,49,54,61,101,114,118],"gamma-glutamylcysteine":[4],"ethyl":[5],"ester":[6],"(gamma-GCE)":[7],"against":[8],"human":[9],"immunodeficiency":[10],"virus":[11],"type":[12],"1":[13],"(HIV-1)-infected":[14],"H-9":[15],"T":[16,122],"lymphocytic":[17,123],"cells":[18],"were":[19,83],"demonstrated":[20],"previously.":[21],"However,":[22],"the":[23,37,45,52,58,97,111,115],"mechanism":[24,113],"those":[26],"remained":[28,73],"unclear.":[29],"Here,":[30],"we":[31],"report":[32],"on":[33],"enhanced":[34],"cytotoxicity":[35,117],"lentiviral":[38],"lytic":[39],"peptide":[40,90],"I":[41],"(LLP-I)":[42],"gp41,":[44],"envelope":[46],"transmembrane":[47],"glycoprotein":[48],"HIV-1,":[50],"in":[51,110,120],"presence":[53],"gamma-GCE.":[55],"Without":[56],"gamma-GCE,":[57,67],"effect":[60,100],"LLP-I":[62,72,104],"was":[63],"transient,":[64],"whereas":[65],"with":[66,86],"cell":[68],"death":[69],"induced":[70],"by":[71,81],"continuous":[74],"until":[75],"termination.":[76],"Of":[77],"note,":[78],"such":[79],"gamma-GCE":[82,102,119],"also":[84],"observed":[85],"another":[87],"unrelated":[88],"amphipathic":[89],"toxin,":[91],"melittin.":[92],"These":[93],"results":[94],"suggest":[95],"that":[96],"synergistic":[98],"and":[103],"may":[105],"play":[106],"a":[107],"central":[108],"role":[109],"molecular":[112],"selective":[116],"HIV-1-infected":[121],"cells.":[124]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2042899751","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
